Trip.com Group Ltd

TRPCF

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

**Signal Note:** This signal does not appear biotech-relevant.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 1,072,741Value: $77.1M

**Signal Note:** This signal does not appear biotech-relevant. Trip.com (TRPCF) is a Chinese online travel platform; Driehaus's initiation likely reflects valuation opportunities in beaten-down travel/tech stocks rather than biotech-specific thesis. The $77.1M position represents a diversification move outside core biotech allocations, possibly capitalizing on post-COVID travel recovery or macro dislocation in Chinese equities.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: